These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 33243038)

  • 1. An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis.
    Cosmi B
    Expert Opin Pharmacother; 2021 Apr; 22(5):583-594. PubMed ID: 33243038
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis.
    Attard LM; Gatt A; Bertoletti L; Delluc A; Riva N
    Vasc Health Risk Manag; 2022; 18():793-807. PubMed ID: 36268462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
    O'Connell C; Escalante CP; Goldhaber SZ; McBane R; Connors JM; Raskob GE
    Oncologist; 2021 Jan; 26(1):e8-e16. PubMed ID: 33275319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism.
    Martins MA; Silva TF; Fernandes CJ
    Curr Oncol Rep; 2023 May; 25(5):425-432. PubMed ID: 36928825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis.
    Li A; Garcia DA; Lyman GH; Carrier M
    Thromb Res; 2019 Jan; 173():158-163. PubMed ID: 29506866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants.
    Carrier M; Soff G; Le Gal G
    Cancer Treat Res; 2019; 179():103-115. PubMed ID: 31317483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer.
    Wang Y; Wang M; Ni Y; Liang Z
    Hematology; 2020 Dec; 25(1):63-70. PubMed ID: 31984870
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.
    Franco-Moreno A; Cabezón-Gutiérrez L; Palka-Kotlowsa M; Villamayor-Delgado M; García-Navarro M
    J Thromb Thrombolysis; 2019 Apr; 47(3):409-419. PubMed ID: 30467760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?
    Voigtlaender M; Langer F
    Hamostaseologie; 2017 Oct; 37(4):241-255. PubMed ID: 28508916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management.
    Riess H; Verhamme P; Weitz JI; Young A; Bauersachs R; Beyer-Westendorf J; Crowther M; Maraveyas A
    Crit Rev Oncol Hematol; 2021 Jan; 157():103125. PubMed ID: 33254037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated thrombosis - treatment and prevention with direct oral factor Xa inhibitors.
    Grilusová K; Bolek T; Škorňová I; Staško J; Samoš M; Mokáň M
    Klin Onkol; 2021; 34(4):283-290. PubMed ID: 34905929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts.
    Bazarbashi S; El Zawahry HM; Owaidah T; AlBader MA; Warsi A; Marashi M; Dawoud E; Jaafar H; Sholkamy SM; Haddad F; Cohen AT
    J Blood Med; 2024; 15():171-189. PubMed ID: 38686358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
    Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
    J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain.
    Muñoz A; Gallardo E; Agnelli G; Crespo C; Forghani M; Arumi D; Fernández de Cabo S; Soto J
    J Med Econ; 2022; 25(1):840-847. PubMed ID: 35703036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study.
    Klamroth R; Sinn M; Pollich C; Bischoff S; Lohneis A; Orlovic AM; Wisłocka L; Habbel P; de Wit M; Späth-Schwalbe E; Scholz CW; Riess H
    Oncol Res Treat; 2022; 45(4):178-185. PubMed ID: 34963120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
    Vedovati MC; Giustozzi M; Becattini C
    Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
    Kirkilesis GI; Kakkos SK; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Management of Cancer-associated Venous Thromboembolism: Focus on Direct Oral Anticoagulants.
    Kim SA; Yhim HY; Bang SM
    J Korean Med Sci; 2019 Feb; 34(6):e52. PubMed ID: 30787683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.
    Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C
    PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis.
    Riaz IB; Fuentes HE; Naqvi SAA; He H; Sipra QR; Tafur AJ; Padranos L; Wysokinski WE; Marshall AL; Vandvik PO; Montori V; Bryce AH; Liu H; Badgett RG; Murad MH; McBane RD
    Mayo Clin Proc; 2022 Feb; 97(2):308-324. PubMed ID: 34172290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.